Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Decorin suppresses tumor cell-mediated angiogenesis

Abstract

The progressive growth of most neoplasms is dependent upon the establishment of new blood vessels, a process regulated by tumor-secreted factors and matrix proteins. We examined the in vitro and in vivo angiogenic ability of conditioned media obtained from fibrosarcoma, carcinoma, and osteosarcoma cells and their decorin-transfected counterparts. Human endothelial cells were investigated in vitro by evaluating three essential steps of angiogenesis: migration, attachment, and differentiation. On the whole, wild-type tumor cell-secretions enhanced endothelial cell attachment, migration, and differentiation, whereas their decorin-expressing forms inhibited these processes. Similarly, decorin-containing media suppressed endothelial cell sprouting in an ex vivo aortic ring assay. Since angiogenesis is an important component of tumor expansion, the growth rate of these cells as tumor xenografts was examined by implantation in nude mice. In vivo, the decorin-expressing tumor xenografts grew at markedly lower rates and showed a significant suppression of neovascularization. Immunohistochemical, Northern and Western blot analyses indicated that the decorin-expressing cells produced vascular endothelial growth factor (VEGF) at markedly reduced rates vis-á-vis their wild-type counterparts. Specificity of this process was confirmed by experiments where addition of recombinant decorin to the wild-type tumor cells caused 80–95% suppression of VEGF mRNA and protein. These results provide a novel mechanism of action for decorin, and indicate that decorin could adversely affect in vivo tumor growth by suppressing the endogenous tumor cell production of a powerful angiogenic stimulus.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

Abbreviations

VEGF:

vascular endothelial growth factors

FGF2:

fibroblast growth factor 2 also known as basic FGF

EGFR:

epidermal growth factor receptor

HUVEC:

human umbilical vein endothelial cells

SFM:

serum-free medium

SDS–PAGE:

Na dodecylsulfate polyacrylamide gel electrophoresis

DPBS:

Dulbecco's phosphate buffered saline

References

  • Abe T, Okamura K, Ono M, Kohno K, Mori T, Hori S, Kuwano M . 1993 J. Clin. Invest. 92: 54–61

  • Adany R, Heimer R, Caterson B, Sorrell JM, Iozzo RV . 1990 J. Biol. Chem. 265: 11389–11396

  • Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN . 1987 Cancer Res. 47: 3239–3245

  • Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A . 1994 Cell 79: 1005–1013

  • Balsari A, Maier JAM, Golnaghi MI, Ménard S . 1999 Lab. Invest. 79: 897–902

  • Bianco P, Riminucci M, Fisher LW . 1993 Dermatan Sulphate Proteoglycans Scott JE (ed) London: Portland Press. pp. 193–205

    Google Scholar 

  • Bidanset D, LeBaron R, Rosenberg L, Murphy-Ullrich JE, Höök M . 1992 J. Cell. Biol. 118: 1523–1531

  • Cheng S-Y, Huang H-JS, Nagane M, Ji X-D, Wang D, Shih CC-Y, Arap W, Huang C-M, Cavenee WK . 1996 Proc. Natl. Acad. Sci. USA 93: 8502–8507

  • Coppock DL, Kopman C, Scandalis S, Gilleran S . 1993 Cell Growth Differ. 4: 483–493

  • Csordás G, Santra M, Reed CC, Eichstetter I, McQuillan D, Gross D, Nugent MA, Hajnóczky G, Iozzo RV . 2000 J. Biol. Chem. 275: 32879–32887

  • Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV . 1997 J. Cell. Biol. 136: 729–743

  • de Lange Davies C, Melder RJ, Munn LL, Mouta-Carreira C, Jain RK, Boucher Y . 2001 Microvasc. Res. 62: 26–42

  • De Luca A, Santra M, Baldi A, Giordano A, Iozzo RV . 1996 J. Biol. Chem. 271: 18961–18965

  • Esko JD, Rostand KS, Weinke JL . 1988 Science 241: 1092–1096

  • Filmus J, Selleck SB . 2001 J. Clin. Invest. 108: 497–501

  • Fisher LW, Stubbs III JT, Young MF . 1995 Acta Orthop. Scand. 66: 61–65

  • Folkman J, D'Amore PA . 1996 Cell 87: 1153–1155

  • Folkman J, Haudenschild CC, Zetter BR . 1979 Proc. Natl. Acad. Sci. USA 76: 5217–5221

  • Garrido T, Riese HH, Aracil M, Pérez-Aranda A . 1995 Br. J. Cancer 71: 770–775

  • Ghiselli G, Eichstetter I, Iozzo RV . 2001 Biochem. J. 359: 153–163

  • Grant DS, Tashiro K-I, Segui-Real B, Yamada Y, Martin GR, Kleinman HK . 1989 Cell 58: 933–943

  • Hanahan D, Folkman J . 1996 Cell 86: 353–364

  • Iozzo RV . 1998 Annu. Rev. Biochem. 67: 609–652

  • Iozzo RV . 1999 J. Biol. Chem. 274: 18843–18846

  • Iozzo RV . 2001 J. Clin. Invest. 108: 165–167

  • Iozzo RV, Moscatello D, McQuillan DJ, Eichstetter I . 1999 J. Biol. Chem. 274: 4489–4492

  • Iozzo RV, San Antonio JD . 2001 J. Clin. Invest. 108: 349–355

  • Järveläinen HT, Iruela-Arispe ML, Kinsella MG, Sandell LJ, Sange EH, Wight TN . 1992 Exp. Cell Res. 203: 395–401

  • Järveläinen HT, Kinsella MG, Wight TN, Sandell LJ . 1991 J. Biol. Chem. 266: 23274–23281

  • Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D . 1991 Cell 66: 1095–1104

  • Kinsella MG, Fischer JW, Mason DP, Wight TN . 2000 J. Biol. Chem. 275: 13924–13932

  • Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR . 1986 Biochemistry 25: 312–318

  • Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, Martin GR . 1982 Biochemistry 24: 6188–6193

  • Klezovitch O, Edelstein C, Zhu L, Scanu AM . 1998 J. Biol. Chem. 273: 23856–23865

  • Kobe B, Deisenhofer J . 1993 Nature 366: 751–756

  • Kresse H, Schönherr E . 2001 J. Cell. Physiol. 189: 266–274

  • Mann DM, Yamaguchi Y, Bourdon MA, Ruoslahti E . 1990 J. Biol. Chem. 265: 5317–5323

  • Mauviel A, Santra M, Chen YQ, Uitto J, Iozzo RV . 1995 J. Biol. Chem. 270: 11692–11700

  • Mongiat M, Taylor K, Otto J, Aho S, Uitto J, Whitelock J, Iozzo RV . 2000 J. Biol. Chem. 275: 7095–7100

  • Moscatello D, Santra M, Mann DM, McQuillan D, Wong AJ, Iozzo RV . 1998 J Clin Invest 101: 406–412

  • Nelimarkka L, Salminen H, Kuopio T, Nikkari S, Ekfors T, Laine J, Pelliniemi L, Järveläinen H . 2001 Am. J. Pathol. 158: 345–353

  • Nicosia RF, Madri JA . 1987 Am. J. Pathol. 128: 78–90

  • Nicosia RF, Ottinetti A . 1990 Lab. Invest. 63: 115–122

  • O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J . 1997 Cell 88: 277–285

  • Petit AMV, Rak J, Hung M-C, Rockwell P, Goldstein N, Fendly B, Kerbel RS . 1997 Am. J. Pathol. 151: 1523–1530

  • Polakowski IJ, Lewis MK, Muthukkaruppan VR, Erdman B, Kubai L, Auerbach R . 1993 Am. J. Pathol. 143: 507–517

  • Reed CC, Gauldie J, Iozzo RV . 2002 Oncogene 21: 3688–3695

  • Risau W . 1995 FASEB J. 9: 926–933

  • Risau W . 1997 Nature 386: 671–674

  • Sage EH . 1997 Trends Cell Biol. 7: 182–186

  • Saksela O, Moscatelli D, Sommer A, Rifkin DB . 1988 J. Cell. Biol. 107: 743–751

  • Saksela O, Rifkin DB . 1990 J. Cell. Biol. 110: 767–775

  • Santra M, Eichstetter I, Iozzo RV . 2000 J. Biol. Chem. 275: 35153–35161

  • Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B, Iozzo RV . 1997 J. Clin. Invest. 100: 149–157

  • Santra M, Skorski T, Calabretta B, Lattime EC, Iozzo RV . 1995 Proc. Natl. Acad. Sci. USA 92: 7016–7020

  • Schmidt G, Robenek H, Harrach B, Glössl J, Nolte V, Hörmann H, Richter H, Kresse H . 1987 J. Cell. Biol. 104: 1683–1691

  • Scholzen T, Solursh M, Suzuki S, Reiter R, Morgan JL, Buchberg AM, Siracusa LD, Iozzo RV . 1994 J. Biol. Chem. 269: 28270–28281

  • Schönherr E, Levkau B, Schaefer L, Kresse H, Walsh K . 2001 J. Biol. Chem. 276: 40687–40692

  • Schönherr E, O'Connell BC, Schittny J, Robenek H, Fastermann D, Fisher LW, Plenz G, Vischer P, Young MF, Kresse H . 1999 Eur. J. Cell Biol. 78: 44–55

  • Vogel KG, Paulsson M, Heinegård D . 1984 Biochem. J. 223: 587–597

  • Weber IT, Harrison RW, Iozzo RV . 1996 J. Biol. Chem. 271: 31767–31770

  • Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J . 1994 Am. J. Pathol. 143: 401–409

  • Weidner N, Semple JP, Welch WR, Folkman J . 1991 New Engl. J. Med. 324: 1–8

  • Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA . 1996 J. Biol. Chem. 271: 10079–10086

  • Yang VWC, LaBrenz SR, Rosenberg LC, McQuillan D, Höök M . 1999 J. Biol. Chem. 274: 12454–12460

Download references

Acknowledgements

We thank J Pope for help with the quantization of the vessels in the mouse tumors, and J Caro, L Fisher and D Mann for providing valuable reagents. This work was supported by grants from the Landenberger Research Foundation and Merck Pharmaceuticals, Rahway N.J. (DS Grant) and from the National Institutes of Health grants RO1 CA39481 and RO1 CA47282, and grants from the Department of the Army, DAMD17-00-1-0663 and DAMD17-00-1-0425 (RV Iozzo), and from the Turkish Scientific Technical and Research Council (TÜBITAK) (C Yenisey).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Renato V Iozzo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grant, D., Yenisey, C., Rose, R. et al. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 21, 4765–4777 (2002). https://doi.org/10.1038/sj.onc.1205595

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205595

Keywords

This article is cited by

Search

Quick links